Oceania · Regional markets · Stockhead
Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review
A review of blinded data from Recce’s Phase III trial of its RECCE 327 Gel in diabetic foot infections has ... Read More The post Recce topical gel shows strong diabetic foot…
Read the full article on Stockhead Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stockhead.com.au)




